Skip to main content
. 2014 Mar 18;143(1):71–80. doi: 10.1017/S0950268814000466

Table 7.

Comparison between sustained virological response (SVR) and non-SVR in HCV patients with IL-10 genotypes

Genotype SVR (n = 98) Non-SVR (n = 52) OR (95% CI) P value Allele frequency
SVR Non-SVR
IL-10 AA 47 (48%) 17 (33%) 1 (Ref.) 0·71 0·53
 −1082A/G AG 46 (47%) 21 (40%) 1·26 (0·59–2·69) 0·54
 (MnII) GG 5 (5%) 14 (27%) 7·7 (2·42–24·74) 0·00* 0·29 0·47
IL-10 CC 36 (37%) 12 (23%) 1 (Ref.) 0·62 0·51
 −819C/T CT 50 (51%) 29 (56%) 1·7 (0·78–3·86) 0·17
 (MaeIII) TT 12 (12%) 11 (21%) 2·7 (0·96–7·83) 0·06 0·38 0·49
IL-10 AA 24 (24·5%) 4 (8%) 1 (Ref.) 0·37 0·17
 −592A/C AC 26 (26·5%) 10 (19%) 2·3 (0·64–8·34) 0·2
 (RsaI) CC 48 (49%) 38 (73%) 4·7 (1·51–14·86) 0·00* 0·63 0·83

Ref., reference category; OR, odds ratio; CI, confidence interval.

*

P < 0·05 is considered statistically significant.